Who is sponsoring NCT06039514?

NCT06039514 is sponsored by University of Valencia.

What drugs are being tested in NCT06039514?

Interventions in NCT06039514: GGTCA-AD mobile app, GGNeutra mobile app.

What condition does NCT06039514 study?

NCT06039514 studies Eating Disorders in Adolescence.

Is NCT06039514 still recruiting?

NCT06039514 is currently completed. Last updated 18 June 2024.

Last reviewed 2024-06-18 · How we verify

NCT06039514

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mobile App for Eating Disorders in Adolescents

Completed NA Last updated 18 June 2024

What this trial tests

NA trial testing GGTCA-AD mobile app in Eating Disorders in Adolescence in 93 participants. Completed in 23 May 2024.

Timeline

9 April 2024

Primary endpoint
23 May 2024

23 May 2024

Quick facts

Lead sponsor	University of Valencia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	93
Start date	9 April 2024
Primary completion	23 May 2024
Estimated completion	23 May 2024
Sites	1 location across Spain

Drugs / interventions tested

GGTCA-AD mobile app
GGNeutra mobile app

Conditions studied

Eating Disorders in Adolescence — all drugs for Eating Disorders in Adolescence →

Sponsor

University of Valencia

Who can join

Adults 13 to 15, any sex, with Eating Disorders in Adolescence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the effectiveness of GGTCA-AD to decrease the maladaptive beliefs associated with eating disorders (ED) in non-clinical adolescent population. Specifically, a randomized controlled trial with parallel design and two groups (experimental and control) will be carried out in adolescents aged 13-15 years to assess the changes pre and post use of the app. It is expected that after the use of the GGTCA-AD app for 14 days, at the primary level, a: decrease in the degree of ascription to dysfunctional beliefs associated with ED; and at the secondary level: increase in body satisfaction and self-esteem; decrease in eating symptomatology; and no changes in emotional symptomatology. These results are also expected to be maintained in subsequent follow-up at 1 month.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Cognitive training via mobile app for addressing eating disorders' cognitions in adolescents: a randomized control trial protocol.
Corberán M, Arnáez S, Saman Y, Pascual-Vera B, et al · · 2024 · cited 1× · PMID 38745260 · DOI 10.1186/s40359-024-01772-z
Cognitive training via mobile app for addressing eating disorders’ cognitions in adolescents: a randomized control trial protocol
Corberán M, Arnáez S, Saman Y, Pascual-Vera B, et al · · 2024 · DOI 10.21203/rs.3.rs-3936622/v1

Verify or expand the search:

Other recruiting trials for Eating Disorders in Adolescence

Currently open trials in the same condition.

NCT06792981 — Evaluation of a Digital School-Based Intervention for the Primary Prevention of Eating Disorders in Pre-Adolescents (PRE · NA · recruiting
NCT04127214 — The ITA Model of Integrated Treatment of Eating Disorders · active not recruiting

Other University of Valencia trials

Trials by the same sponsor.

NCT07509281 — Peri-implant Tissues Changes for Different Abutment Shapes and Heights · NA · not yet recruiting
NCT07535528 — Implant Placement Depth and Peri-Implant Tissue Outcomes · NA · not yet recruiting
NCT07471555 — Vascular Access and Intraosseus · NA · enrolling by invitation
NCT07463066 — Long-Term Effectiveness of Pain Neuroscience Education in Women With Genito-Pelvic Pain/Penetration Disorder. · not yet recruiting
NCT07419399 — Acute Effects of Radiofrequency Diathermy in Postpartum Women With Diastasis Abdominis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06039514 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Valencia
Last refreshed: 18 June 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06039514.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing